Sam Brusco, Associate Editor11.10.23
TekniPlex Healthcare has begun a deal to acquire Seisa Medical. The acquisition will augment the company’s material science and process technologies for minimally invasive and interventional therapy devices.
El Paso, Texas-based Seisa is a medical device manufacturing firm servicing design and development, component manufacturing, and final assembly. The company employs over 2,000 people across four facilities in the U.S., Mexico, and Slovakia.
This marks the 20th acquisition TekniPlex has made in the past decade in order to grow its business through transformative acquisitions and strategic add-ons.
“This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the CDMO (contract, development, and manufacturing organization) segment of MedTech for medical technologies,” TekniPlex CEO Chris Qualters told the press. “The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes.”
Julio Chiu, Seisa founder and CEO, added, “Our customers count on us to deliver solutions for their most challenging applications. I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.”
El Paso, Texas-based Seisa is a medical device manufacturing firm servicing design and development, component manufacturing, and final assembly. The company employs over 2,000 people across four facilities in the U.S., Mexico, and Slovakia.
This marks the 20th acquisition TekniPlex has made in the past decade in order to grow its business through transformative acquisitions and strategic add-ons.
“This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the CDMO (contract, development, and manufacturing organization) segment of MedTech for medical technologies,” TekniPlex CEO Chris Qualters told the press. “The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes.”
Julio Chiu, Seisa founder and CEO, added, “Our customers count on us to deliver solutions for their most challenging applications. I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.”